Breccia M, Salaroli A, Loglisci G, Finsinger P, Serrao A, Alimena G. MDS-specific comorbidity index is useful to identify myelodysplastic patients who can have better outcome with 5-azacitidine. Haematologica 2012; 97(2):e2-e2; https://doi.org/10.3324/haematol.2011.059808.